China Regenerative Medicine International Ltd 2024 Annual Report with Sustainability Disclosures
Company: China Regenerative Medicine International Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 206
The report records 2024 revenue of approximately HK$90.62 million and a turnaround to approximately HK$17.75 million profit. Its ESG report covers the Group's Hong Kong-led reporting boundary, with the Board holding overall ESG responsibility and an ESG Taskforce supporting oversight. The environmental KPI tables report total GHG emissions of 31.44 tCO2e, entirely identified as Scope 2 in the table.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.